Skip to main content
PHARMA-COMPLIANCE5 MIN READ

Risk-Based Monitoring Escalation

Escalate a clinical monitoring signal based on critical-to-quality impact and participant risk.

Signal A high-deviation site also has delayed AE entry before a dosing cycle. The signal may affect participant safety, not just dashboard color. RBM escalation Signal -> CTQ Impact -> Action -> Review Oversight intensity should follow what the signal threatens. Risk-based monitoring focuses resources on participant protection and reliable critical data. Step 1 Classify The Signal The site has high protocol deviations and delayed AE entry. What should the team determine first? Step 2 Pick The Oversight Action AE delays could affect dosing review within 48 hours. Which action fits the risk? Now You Try Fresh Application A low-enrolling…

Read the full lesson

Sign up free — one personalized lesson every day, matched to your role and goals.

Already have an account? Sign in

← Back to library
Contact us